药理学上升的catecholamine水平提高了感知决策,但不是元认知洞察力
Stijn A Nuiten1,2,3, Jan Willem de Gee2,4, Jasper B Zantvoord5,6
1Department of Psychology, University of Amsterdam, Amsterdam, Netherlands stijn.nuiten@gmail.com simonvangaal@gmail.com.
eNeuro
|July 19, 2024
概括
提升的甲基荷胺水平可以提高视觉感知,但不能提高决策信心. 这项研究发现,增强甲基荷兰胺增加了感知灵敏度,而元认知灵敏度保持不变,以不同的方式影响大脑信号.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
- 心理学 心理学 心理学
背景情况:
- 感知决策涉及头顶皮层,而信任判断则招募前额叶区域.
- 内部和外部因素可能会对感知和元认知决策产生不同的影响.
- 对于不同的神经机制的因果关系证据有限.
研究的目的:
- 为了调查catecholamines和乙胆在感知和元认知决策中的因果作用.
- 为了检查这些神经调节器对行为和神经测量的影响.
- 测试对感知与元认知过程产生不同影响的假设.
主要方法:
- 健康的成年人接受了atomoxetine (catecholamine增强剂) 或donepezil (乙胆增强剂).
- 参与者执行了一项视觉歧视任务,测量决策信心.
- 脑电图 (EEG) 记录了任务期间的神经活动.
主要成果:
- 胆固醇增强没有显示出强大的效果.
- katekholaminergic 增强改善了感知灵敏度,但并没有提高元认知灵敏度.
- 在神经层面上,甲基荷胺增强了中心关节决策信号,但降低了额头元认知标记.
结论:
- 增强的catecholaminergic神经调节通过增强证据积累来改善感知决策.
- 超认知决策,特别是信任评估,并没有得到由catecholaminergic增强改善.
- 研究结果表明,受catecholamines影响的感知和元认知过程具有不同的神经通路.
关键词:
这是一个EEGEEGEEGEEGEEGEEGEEG.乙烯基胆是一种激发性兴奋 激发性兴奋类甲基胺 (Catecholamines) 是一种类甲基胺.这是一种元认知 (metacognition).感知 感知 感知 感知更多相关视频
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
14.6K
09:43The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
46.0K
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
114
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
114
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
01:28Adrenergic Agonists: Mixed-Action Agents
700
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
700
01:30Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
01:30Adrenergic Agonists: Therapeutic Uses
760
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
760